UnitedHealth Group has signaled a recovery from a challenging 2025, posting first-quarter results that exceeded analyst expectations on both top and bottom lines. The healthcare giant subsequently raised its full-year profit outlook, sparking a sharp rally in its share price.
- Q1 revenue reached $111.72 billion, exceeding analyst expectations
- Adjusted EPS of $7.23 outperformed the $6.57 consensus
- Full-year adjusted earnings guidance increased to $18.25 per share
- Company is exiting non-U.S. businesses to refocus on domestic healthcare
- Shares surged over 9% following the announcement
- Jefferies raised price target to $373
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.
Share this article